Pertuzumab : evolving therapeutic strategies in the management of HER2-overexpressing breast cancer.
about
Pertuzumab in Combination with Trastuzumab and Chemotherapy in the Treatment of HER2-Positive Metastatic Breast Cancer: Safety, Efficacy, and Progression Free Survival.Disulfide bond disrupting agents activate the unfolded protein response in EGFR- and HER2-positive breast tumor cells.Prognostic role of HER2 expression in bladder cancer: a systematic review and meta-analysis.Bidirectional Crosstalk between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Signaling Pathways in Breast Cancer: Molecular Basis and Clinical Implications.Clinical applications of mouse models for breast cancer engaging HER2/neu.
P2860
Pertuzumab : evolving therapeutic strategies in the management of HER2-overexpressing breast cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pertuzumab : evolving therapeu ...... -overexpressing breast cancer.
@en
type
label
Pertuzumab : evolving therapeu ...... -overexpressing breast cancer.
@en
prefLabel
Pertuzumab : evolving therapeu ...... -overexpressing breast cancer.
@en
P2860
P1476
Pertuzumab : evolving therapeu ...... -overexpressing breast cancer.
@en
P2093
Ciara C O'Sullivan
P2860
P304
P356
10.1517/14712598.2013.783007
P407
P577
2013-03-27T00:00:00Z